Clinical Data Science
Disciplined data and analysis that strengthen every decision.
* Confident * Flexible * Compliant * Urgent * Consultative * Global
* Confident * Flexible * Compliant * Urgent * Consultative * Global
* Confident * Flexible * Compliant * Urgent * Consultative * Global
* Confident * Flexible * Compliant * Urgent * Consultative * Global
* Confident * Flexible * Compliant * Urgent * Consultative * Global
* Confident * Flexible * Compliant * Urgent * Consultative * Global
* Confident * Flexible * Compliant * Urgent * Consultative * Global
* Confident * Flexible * Compliant * Urgent * Consultative * Global
DISCIPLINE MEETS ADAPTIVE EXECUTION
Why The Modern Global CRO Matters
Clinical development is evolving—demanding faster decisions, cleaner data, and transparent communication at every step. Harvest Integrated Research Organization (HiRO) is a full-service global CRO built for this reality, delivering end-to-end clinical trial services through connected teams, advanced clinical data science, and globally aligned operational frameworks.
As The Modern Global CRO, we bring structure to complexity without sacrificing adaptability. Our approach strengthens predictability across every phase of the trial, giving sponsors the confidence to act decisively while staying aligned, informed, and in control as studies scale.
30
Years of Experience
04
Regions Served
400+
Professionals Across the Globe
400
Global Site Partnerships
MODERN MEANS DISCIPLINED, TRANSPARENT, AND DESIGNED FOR TODAY’S TRIALS
Biotechs Turn to HiRO for
Modern CRO Services Built to Scale
Our teams combine biometrics-driven discipline with connected systems and region-specific operational insight, delivering CRO services that scale without sacrificing clarity, consistency, or control across today’s complex clinical programs.
Clinical Operations
Predictable, regionally informed study execution grounded in steady oversight, proactive site engagement, and disciplined coordination.
Quality Assurance
Inspection-ready governance with structured processes, continuous review, and documentation that stands up to scrutiny.
Medical Monitoring
Consistent clinical oversight with timely medical review, safety evaluation, and clear communication throughout your program.
Regulatory Affairs
Clear, compliant guidance supported by global standards, transparent documentation, and steady alignment with regional requirements.
Pharmacovigilance
Reliable safety oversight supported by disciplined case management, timely reporting, and globally aligned quality standards.
Medical Writing
Accurate, objective documents that translate complex data into clear, regulatory-ready narratives and submissions.
A Modern Full-Service Global CRO Built For What Biotechs Need
WHAT BIOTECHS SEEK IN A MODERN CRO
Powered By The HiRO
Linkage™ Approach
WHAT GLOBAL BIOTECHS ARE SAYING
Real Experiences From Global Teams Who Rely On HiRO
Biotechs and pharmas across the globe trust HiRO for clarity, alignment, and delivery that stays consistent from startup through closeout.
“Your proven ability to manage the project at top-notch global quality standards, while maintaining flexibility, is why we love working with HiRO.”
Biotech Company (APAC)
“The Operations team we work with is highly experienced, making work across a +7-hour time difference super easy and stress-free.”
Pharmaceutical Company (Europe)
“Over the past three months, the HiRO Project Team has provided frequent transparent check-ins, day and night, ensuring we reach our milestone.”
Biotech Company (APAC)
“I have truly loved working with the HiRO team! Their support and enthusiasm contributed to the success of this study, and we truly appreciate it.”
Pharmaceutical Company (U.S.)
Ready For A Partner Who
Brings Clarity To Complexity?
THE LATEST FROM HiRO GLOBAL AND THE CRO MARKET
HiRO Global Is Making Moves,
and The World Is Watching.
HiRO Leads Cross‑Border Dialogue at JPM, Offering Insights for Biotechs Seeking Asian Investment
HiRO Leads Cross‑Border Dialogue at JPM, Offering Insights for Biotechs Seeking Asian Investment
Read More
Successful Rescue and Transition of a Phase I Oncology Study for a US Biotech Company
Successful Rescue and Transition of a Phase I Oncology Study for a US Biotech Company
Read More
Rescuing a Rare Disease Trial: Accelerating MRCT RA Submissions for a Taiwan Biotech Company
